These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 27213345)

  • 1. Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
    Leopold JA; Maron BA
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA and Pulmonary Hypertension.
    Boucherat O; Potus F; Bonnet S
    Adv Exp Med Biol; 2015; 888():237-52. PubMed ID: 26663186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances in molecular mechanism of vascular remodeling in pulmonary arterial hypertension].
    Xiao L; Tong X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2019 May; 48(1):102-110. PubMed ID: 31102364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal Mechanisms of Vascular Remodeling in the Development of Pulmonary Arterial Hypertension.
    Li MX; Jiang DQ; Wang Y; Chen QZ; Ma YJ; Yu SS; Wang Y
    J Cardiovasc Pharmacol; 2016 Feb; 67(2):182-90. PubMed ID: 26448276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Vascular Remodeling to Treat Pulmonary Arterial Hypertension.
    Thompson AAR; Lawrie A
    Trends Mol Med; 2017 Jan; 23(1):31-45. PubMed ID: 27989641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
    Orriols M; Gomez-Puerto MC; Ten Dijke P
    Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Ablation of PDGF-Dependent Signaling Pathways Abolishes Vascular Remodeling and Experimental Pulmonary Hypertension.
    Ten Freyhaus H; Berghausen EM; Janssen W; Leuchs M; Zierden M; Murmann K; Klinke A; Vantler M; Caglayan E; Kramer T; Baldus S; Schermuly RT; Tallquist MD; Rosenkranz S
    Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1236-45. PubMed ID: 25745058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-27a promotes endothelial-mesenchymal transition in hypoxia-induced pulmonary arterial hypertension by suppressing BMP signaling.
    Liu T; Zou XZ; Huang N; Ge XY; Yao MZ; Liu H; Zhang Z; Hu CP
    Life Sci; 2019 Jun; 227():64-73. PubMed ID: 31004656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging role of microRNAs in hypoxia-induced pulmonary hypertension.
    Mohsenin V
    Sleep Breath; 2016 Sep; 20(3):1059-67. PubMed ID: 27154628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-κB mediated miR-130a modulation in lung microvascular cell remodeling: Implication in pulmonary hypertension.
    Li L; Kim IK; Chiasson V; Chatterjee P; Gupta S
    Exp Cell Res; 2017 Oct; 359(1):235-242. PubMed ID: 28755990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of prolyl hydroxylase domain protein 2 in vascular endothelium increases pericyte coverage and promotes pulmonary arterial remodeling.
    Wang S; Zeng H; Xie XJ; Tao YK; He X; Roman RJ; Aschner JL; Chen JX
    Oncotarget; 2016 Sep; 7(37):58848-58861. PubMed ID: 27613846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in pulmonary arterial remodeling.
    Grant JS; White K; MacLean MR; Baker AH
    Cell Mol Life Sci; 2013 Dec; 70(23):4479-94. PubMed ID: 23739951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salidroside attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A2a receptor related mitochondria-dependent apoptosis pathway.
    Huang X; Zou L; Yu X; Chen M; Guo R; Cai H; Yao D; Xu X; Chen Y; Ding C; Cai X; Wang L
    J Mol Cell Cardiol; 2015 May; 82():153-66. PubMed ID: 25772255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvianolic acid A attenuates vascular remodeling in a pulmonary arterial hypertension rat model.
    Chen YC; Yuan TY; Zhang HF; Wang DS; Yan Y; Niu ZR; Lin YH; Fang LH; Du GH
    Acta Pharmacol Sin; 2016 Jun; 37(6):772-82. PubMed ID: 27180980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA networks in pulmonary arterial hypertension: share mechanisms with cancer?
    Courboulin A; Ranchoux B; Cohen-Kaminsky S; Perros F; Bonnet S
    Curr Opin Oncol; 2016 Jan; 28(1):72-82. PubMed ID: 26569423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA Damage and Pulmonary Hypertension.
    Ranchoux B; Meloche J; Paulin R; Boucherat O; Provencher S; Bonnet S
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome Proliferator-Activated Receptor γ and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling.
    Kang BY; Park KK; Kleinhenz JM; Murphy TC; Green DE; Bijli KM; Yeligar SM; Carthan KA; Searles CD; Sutliff RL; Hart CM
    Am J Respir Cell Mol Biol; 2016 Jan; 54(1):136-46. PubMed ID: 26098770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occlusive lung arterial lesions in endothelial-targeted, fas-induced apoptosis transgenic mice.
    Goldthorpe H; Jiang JY; Taha M; Deng Y; Sinclair T; Ge CX; Jurasz P; Turksen K; Mei SH; Stewart DJ
    Am J Respir Cell Mol Biol; 2015 Nov; 53(5):712-8. PubMed ID: 25879383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary arterial hypertension: pathogenesis and clinical management.
    Thenappan T; Ormiston ML; Ryan JJ; Archer SL
    BMJ; 2018 Mar; 360():j5492. PubMed ID: 29540357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-145-targeted drug and its preventive effect on pulmonary arterial hypertension (patent WO2012153135 A1).
    Ogorodnikova N; Arenz C
    Expert Opin Ther Pat; 2015 Jun; 25(6):723-7. PubMed ID: 25787302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.